Relay Therapeutics
RLAY
RLAY
188 hedge funds and large institutions have $1.1B invested in Relay Therapeutics in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 51 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2.96% less ownership
Funds ownership: 103.82% → 100.86% (-3%)
22% less capital invested
Capital invested by funds: $1.41B → $1.1B (-$310M)
38% less call options, than puts
Call options by funds: $61K | Put options by funds: $98K
Holders
188
Holding in Top 10
4
Calls
$61K
Puts
$98K
Top Buyers
| 1 | +$31.1M | |
| 2 | +$20.8M | |
| 3 | +$9.67M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.27M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$8.3M |
Top Sellers
| 1 | -$43.7M | |
| 2 | -$19.5M | |
| 3 | -$14.1M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$8.97M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$7.42M |